The new global clinical guidelines for obesity emphasize the importance of diagnosing obesity using objective health measures rather than relying solely on body mass index (BMI). This shift aims to ensure accurate diagnosis and treatment for over one billion people worldwide living with obesity.
The Lancet Diabetes & Endocrinology Commission has introduced two new categories: clinical obesity, marked by organ dysfunction, and pre-clinical obesity, which carries health risks without complications. This distinction allows for more targeted treatment approaches.
Experts suggest treatment for clinical obesity should focus on restoring body functions impacted by excess fat. In contrast, those with pre-clinical obesity should receive care aimed at reducing their health risks.
The guidelines advocate for a stigma-free approach to treatment, urging healthcare professionals to provide evidence-based care and personalized strategies for managing obesity based on individual health status.
Collection
[
|
...
]